Sunday, November 28, 2021
Home India CDSCO expert panel recommends nod to study on mixing doses of Covaxin,...

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield | India News – Times of India


NEW DELHI: An expert panel of India’s central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a clinical trial of mixing of two Covid-19 vaccines — Covaxin and Covishield — official sources said.
The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word “interchangeability” from the study title and submit a revised protocol for approval.
“The SEC (subject expert committee) after detailed deliberations recommended granting permission to CMC, Vellore for conducting the phase-4 clinical trial covering 300 healthy volunteers for mixing of Covid-19 vaccines Covaxin and Covishield,” a source said.
“The aim of the study is to assess whether a person can be given two different vaccine shots — one each of Covishield and Covaxin — to complete the inoculation course,” the source said.
The expert group also discussed the application by Biological E for conducting Phase 2/3 clinical trial of its Covid-19 vaccine in the paediatric population aged 5 to 17 years, along with the safety and immunogenicity data (after dose 1) from the ongoing phase 2/3 clinical trial on adults.
“After deliberation, the committee recommended that the safety and immunogenicity data from phase 2 part of the phase 2/3 clinical trial on adults should be submitted to the CDSCO (Central Drugs Standard Control Organisation),” the source said.
It also suggested that the firm should submit the clinical trial protocol along with data for further review by the committee, the source said.
The application of Johnson and Johnson (J&J) seeking permission to conduct phase-3 clinical trial of its single-dose Covid-19 vaccine was on the agenda, but “the firm informed that they are withdrawing their proposal,” another official source said.
The US-based pharmaceutical company J&J had sought approval for conducting phase-3 clinical trial of its vaccine on approximately 600 participants in two age groups — those aged between 18 and 59 years and those aged 60 and above — to evaluate the safety, reactogenicity, and immunogenicity of the jab in healthy Indian adults.
The firm has conducted clinical trials in the USA, Brazil and South Africa.
J&J’s single dose vaccine first received the emergency use authorisation (EUA) in Bahrain on 25 February 2021.
As of April 16, 2021, the vaccine has been approved in several countries/markets around the world, including the US and the EU.





Source link

RELATED ARTICLES

Late Left Leader’s Daughter A Trinamool Candidate In Kolkata Civic Poll

<!-- -->Basundhara Goswami has been a left student activist since her college days. (Representational)Kolkata: Basundhara Goswami, the daughter of late RSP heavyweight and...

No need to panic over new Covid-19 variant: ICMR | India News – Times of India

NEW DELHI: Amid mounting concern over cases of the new variant of concern Omicron detected in some countries, the Indian Council of Medical...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -stock market course

Most Popular

Late Left Leader’s Daughter A Trinamool Candidate In Kolkata Civic Poll

<!-- -->Basundhara Goswami has been a left student activist since her college days. (Representational)Kolkata: Basundhara Goswami, the daughter of late RSP heavyweight and...

No need to panic over new Covid-19 variant: ICMR | India News – Times of India

NEW DELHI: Amid mounting concern over cases of the new variant of concern Omicron detected in some countries, the Indian Council of Medical...

Weekly Tarot Card Readings: Tarot prediction for November 28-December 04

ARIES (March 21-April 20)Love: The StrengthMood: The HangedCareer: The EmpressThere are strong possibilities that your efforts to improve your professional standards may bear...

UK, Germany, Italy Detect Cases Of New Covid Variant

<!-- -->New Covid strain: Several nations have imposed restrictions on travel from southern Africa. (File)London/Berlin/Amsterdam: Britain, Germany and Italy detected cases of the...

Recent Comments

%d bloggers like this: